Click
here to close Hello! We notice that
you are using Internet Explorer, which is not supported by Echinobase
and may cause the site to display incorrectly. We suggest using a
current version of Chrome,
FireFox,
or Safari.
Mining of Ebola virus entry inhibitors identifies approved drugs as two-pore channel pore blockers.
Penny CJ
,
Vassileva K
,
Jha A
,
Yuan Y
,
Chee X
,
Yates E
,
Mazzon M
,
Kilpatrick BS
,
Muallem S
,
Marsh M
,
Rahman T
,
Patel S
.
???displayArticle.abstract???
Two-pore channels (TPCs) are Ca2+-permeable ion channels localised to the endo-lysosomal system where they regulate trafficking of various cargoes including viruses. As a result, TPCs are emerging as important drug targets. However, their pharmacology is ill-defined. There are no approved drugs to target them. And their mechanism of ligand activation is largely unknown. Here, we identify a number of FDA-approved drugs as TPC pore blockers. Using a model of the pore of human TPC2 based on recent structures of mammalian TPCs, we virtually screened a database of ~1500 approved drugs. Because TPCs have recently emerged as novel host factors for Ebola virus entry, we reasoned that Ebola virus entry inhibitors may exert their effects through inhibition of TPCs. Cross-referencing hits from the TPC virtual screen with two recent high throughput anti-Ebola screens yielded approved drugs targeting dopamine and estrogen receptors as common hits. These compounds inhibited endogenous NAADP-evoked Ca2+ release from sea urchin egg homogenates, NAADP-mediated channel activity of TPC2 re-routed to the plasma membrane, and PI(3,5)P2-mediated channel activity of TPC2 expressed in enlarged lysosomes. Mechanistically, single channel analyses showed that the drugs reduced mean open time consistent with a direct action on the pore. Functionally, drug potency in blocking TPC2 activity correlated with inhibition of Ebola virus-like particle entry. Our results expand TPC pharmacology through the identification of approved drugs as novel blockers, support a role for TPCs in Ebola virus entry, and provide insight into the mechanisms underlying channel regulation. This article is part of a Special Issue entitled: ECS Meeting edited by Claus Heizmann, Joachim Krebs and Jacques Haiech.
Fig. 1. A structure-based virtual screen of approved drugs based on the TPC2 pore.A, structural model of human TPC2 viewed from the cytosolic face. The pore region is highlighted by the dashed box.B, results of a virtual screen of the e-Drugs3D database against the pore region of TPC2. The top 200 drugs are marked by the shaded region.C, plots showing the rank of individual drugs from the virtual screen targeting voltage-gated Ca2+ and Na+ channels. The horizontal lines represent the mean. Nicardipine (rank #154) and diltiazem (rank #247) are highlighted*.D, enrichment analysis of drug classes within the top 200 hits. G-protein coupled receptors are highlighted*.
Fig. 2. Identification of drugs targeting dopamine and estrogen receptors as putative TPC2 inhibitors.A, Venn diagram depicting the relationship between approved drugs identified as Ebola virus entry inhibitors in independent high through put screens by Kouznetsova [58] and Johansen et al. [59].B, Venn diagram depicting the relationships between the entry inhibitors identified in A with the e-Drugs3D database used for the TPC virtual screen.C, Venn diagram depicting the relationship between entry inhibitors present in the e-Drugs3-D database and the top 200 hits from the TPC virtual screen.D, prioritised set of 14 drugs identified from C listing their rank in the TPC virtual screen, their reported IC50 values for inhibiting virus entry (from Kouznetsova [58] and/or aJohansen et al. [59]) and their primary target (annotated in e-Drugs3D).
Fig. 3. Ca2+ channel blockers, dopamine antagonists and selective estrogen receptor modulators block endogenous NAADP-mediated Ca2+ signals.A, exemplar Ca2+ signals, recorded using Fluo-4 from sea urchin egg homogenates pre-incubated with the indicated drug (100 μM) or DMSO (black traces) for ~1 min prior to stimulation with NAADP (1 μM).B, concentration-effect relationships for blockade of NAADP responses by the various drugs (n = 3). Data are normalised to the NAADP response in the presence of DMSO.C, summary data quantifying the effect of the drugs (100 μM) on Ca2+ response to NAADP versus cyclic ADP-ribose (n = 3). Data are normalised to the NAADP and cyclic ADP-ribose responses in the presence of DMSO.
Fig. 4. NAADP stimulates single channel activity of TPC2 rerouted to the plasma membrane.A, exemplar single channel recordings from inside-out patches excised from HEK cells expressing plasma membrane-targeted TPC2 in response to the indicated concentrations of NAADP. Na+ was the charge carrier and the holding potential was +40 mV. C denotes the closed state.B, summary data quantifying open probability (NPo; n = 3–28).C, current-voltage relationships derived from records similar to those shown in A (n = 3).D, exemplar open and closed time distributions at the indicated NAADP concentration.E, summary data quantifying mean open time (n = 3–28).F, likely gating schemes for TPC2.
Fig. 5. Dopamine antagonists and selective estrogen receptor modulators inhibit single channel activity of TPC2 by reducing open time.A–C, exemplar single channel records from inside-out patches expressing plasma membrane-targeted TPC2. Patches were sequentially challenged with 100 nM NAADP and either fluphenazine (100 μM; A), raloxifene (100 μM; B) or Ned-19 (1 μM; C). Large vertical deflections are addition artefacts. Red bars indicate the sections of the upper trace in the presence of NAADP before and after drug addition that were expanded in the corresponding lower traces.D–F, exemplar open time distributions from records similar to A–C in the presence of the indicated drug.G, summary data quantifying open probability, mean closed time and unitary conductance for TPC2 activity in response to 100 nM NAADP in the absence (n = 10) and presence of the indicated drug (n = 3–4). (For interpretation of the references to color in this figure legend, the reader is referred to the web version of this article.)
Fig. 6. Dopamine antagonists and selective estrogen receptor modulators inhibit lysosomal TPC2 currents.A, exemplar currents recorded from enlarged lysosomes isolated from HEK cells expressing lysosome-targeted TPC2 in response to PI(3,5)P2 (1 μM). The holding potentials were +100 mV (upper traces) and −100 mV (lower traces). Lysosomes were challenged with fluphenazine (Flu.) and raloxifene (Ral.) at the concentrations and for the times indicated.B, concentration-effect relationships for blockade of PI(3,5)P2 currents by fluphenazine (open circles) and raloxifene (closed circles;n = 2). Data are normalised to the PI(3,5)P2 response in the absence of the drugs.
Fig. 7. Dopamine antagonists and selective estrogen receptor modulators inhibit entry of Ebola virus-like particles.A, infection of HeLa cells with Ebola virus-like particles in the absence and presence of EIPA (11.1 μM; n = 3) or tetrandrine (1.2 μM; n = 4).B, concentration-effect relationships for blockade of virus-like particle entry by the indicated dopamine antagonist (squares) or SERMs (circles). n = 3–4.
Fig. S1. Current amplitude histograms of single channel records from inside-out patches expressing plasma membrane-targeted TPC2.A–C, Histograms in the absence or presence of the indicated concentration of NAADP.D–E, Histograms in the presence NAADP (100 nM) and the indicated drug.
Avdonin,
Dihydropyridine action on voltage-dependent potassium channels expressed in Xenopus oocytes.
1997, Pubmed
Avdonin,
Dihydropyridine action on voltage-dependent potassium channels expressed in Xenopus oocytes.
1997,
Pubmed
Barber,
Blockade of cardiac sodium channels. Competition between the permeant ion and antiarrhythmic drugs.
1992,
Pubmed
Brailoiu,
Essential requirement for two-pore channel 1 in NAADP-mediated calcium signaling.
2009,
Pubmed
Brailoiu,
An NAADP-gated two-pore channel targeted to the plasma membrane uncouples triggering from amplifying Ca2+ signals.
2010,
Pubmed
Cai,
Degeneration of an intracellular ion channel in the primate lineage by relaxation of selective constraints.
2010,
Pubmed
Calcraft,
NAADP mobilizes calcium from acidic organelles through two-pore channels.
2009,
Pubmed
Chandran,
Endosomal proteolysis of the Ebola virus glycoprotein is necessary for infection.
2005,
Pubmed
Cheng,
Inhibition of Ebola and Marburg Virus Entry by G Protein-Coupled Receptor Antagonists.
2015,
Pubmed
Churamani,
Domain assembly of NAADP-gated two-pore channels.
2012,
Pubmed
Churchill,
NAADP mobilizes Ca(2+) from reserve granules, lysosome-related organelles, in sea urchin eggs.
2002,
Pubmed
,
Echinobase
Côté,
Small molecule inhibitors reveal Niemann-Pick C1 is essential for Ebola virus infection.
2011,
Pubmed
Dammermann,
NAADP-mediated Ca2+ signaling via type 1 ryanodine receptor in T cells revealed by a synthetic NAADP antagonist.
2009,
Pubmed
Dickinson,
Modulation of NAADP (nicotinic acid-adenine dinucleotide phosphate) receptors by K+ ions: evidence for multiple NAADP receptor conformations.
2003,
Pubmed
,
Echinobase
Dutertre,
Molecular mechanisms of selective estrogen receptor modulator (SERM) action.
2000,
Pubmed
Enyeart,
Antipsychotic pimozide is a potent Ca2+ channel blocker in heart.
1990,
Pubmed
Galione,
Preparation and use of sea urchin egg homogenates for studying NAADP-mediated Ca²⁺ release.
2014,
Pubmed
,
Echinobase
Genazzani,
Pharmacological properties of the Ca2+-release mechanism sensitive to NAADP in the sea urchin egg.
1997,
Pubmed
,
Echinobase
Grimm,
High susceptibility to fatty liver disease in two-pore channel 2-deficient mice.
2014,
Pubmed
Grimm,
Two-Pore Channels: Catalyzers of Endolysosomal Transport and Function.
2017,
Pubmed
Gunaratne,
NAADP-dependent Ca2+ signaling regulates Middle East respiratory syndrome-coronavirus pseudovirus translocation through the endolysosomal system.
2018,
Pubmed
Gunaratne,
A screening campaign in sea urchin egg homogenate as a platform for discovering modulators of NAADP-dependent Ca2+ signaling in human cells.
2018,
Pubmed
,
Echinobase
Guo,
Structure of the voltage-gated two-pore channel TPC1 from Arabidopsis thaliana.
2016,
Pubmed
Guo,
Tuning the ion selectivity of two-pore channels.
2017,
Pubmed
Guse,
Linking NAADP to ion channel activity: a unifying hypothesis.
2012,
Pubmed
Harper,
Verapamil block of large-conductance Ca-activated K channels in rat aortic myocytes.
2001,
Pubmed
Hockey,
Dysregulation of lysosomal morphology by pathogenic LRRK2 is corrected by TPC2 inhibition.
2015,
Pubmed
Ionescu,
Graded recruitment and inactivation of single InsP3 receptor Ca2+-release channels: implications for quantal [corrected] Ca2+release.
2006,
Pubmed
Jha,
Convergent regulation of the lysosomal two-pore channel-2 by Mg²⁺, NAADP, PI(3,5)P₂ and multiple protein kinases.
2014,
Pubmed
Johansen,
A screen of approved drugs and molecular probes identifies therapeutics with anti-Ebola virus activity.
2015,
Pubmed
Kamer,
MICU1 imparts the mitochondrial uniporter with the ability to discriminate between Ca2+ and Mn2+.
2018,
Pubmed
Kilpatrick,
An Endosomal NAADP-Sensitive Two-Pore Ca2+ Channel Regulates ER-Endosome Membrane Contact Sites to Control Growth Factor Signaling.
2017,
Pubmed
Kintzer,
Structure, inhibition and regulation of two-pore channel TPC1 from Arabidopsis thaliana.
2016,
Pubmed
Kirsch,
Phosphatidylinositol-3,5-bisphosphate lipid-binding-induced activation of the human two-pore channel 2.
2018,
Pubmed
Ko,
GalaxyWEB server for protein structure prediction and refinement.
2012,
Pubmed
Kouznetsova,
Identification of 53 compounds that block Ebola virus-like particle entry via a repurposing screen of approved drugs.
2014,
Pubmed
Kow,
Rapid estrogen actions on ion channels: A survey in search for mechanisms.
2016,
Pubmed
Lavanya,
siRNA screen for genes that affect Junín virus entry uncovers voltage-gated calcium channels as a therapeutic target.
2013,
Pubmed
Lee,
Characterization of Two-Pore Channel 2 by Nuclear Membrane Electrophysiology.
2016,
Pubmed
Lee,
Nicotinic acid adenine dinucleotide phosphate (NAADP)-mediated calcium signaling.
2005,
Pubmed
,
Echinobase
Levin,
Binding of trifluoperazine to the calcium-dependent activator of cyclic nucleotide phosphodiesterase.
1977,
Pubmed
Li,
α-SNAP regulates dynamic, on-site assembly and calcium selectivity of Orai1 channels.
2016,
Pubmed
Lin-Moshier,
The Two-pore channel (TPC) interactome unmasks isoform-specific roles for TPCs in endolysosomal morphology and cell pigmentation.
2014,
Pubmed
Lin-Moshier,
Photoaffinity labeling of nicotinic acid adenine dinucleotide phosphate (NAADP) targets in mammalian cells.
2012,
Pubmed
,
Echinobase
Manicassamy,
Expression of Ebolavirus glycoprotein on the target cells enhances viral entry.
2009,
Pubmed
Manicassamy,
Comprehensive analysis of ebola virus GP1 in viral entry.
2005,
Pubmed
Marchant,
Questioning regulation of two-pore channels by NAADP.
2013,
Pubmed
Marchant,
The Molecular Basis for Ca2+ Signalling by NAADP: Two-Pore Channels in a Complex?
2012,
Pubmed
Marchant,
Two-pore channels at the intersection of endolysosomal membrane traffic.
2015,
Pubmed
Millet,
Host cell entry of Middle East respiratory syndrome coronavirus after two-step, furin-mediated activation of the spike protein.
2014,
Pubmed
Morgan,
Molecular mechanisms of endolysosomal Ca2+ signalling in health and disease.
2011,
Pubmed
Morgan,
Two-pore channels (TPCs): current controversies.
2014,
Pubmed
Naylor,
Identification of a chemical probe for NAADP by virtual screening.
2009,
Pubmed
,
Echinobase
Nguyen,
Two-Pore Channel Function Is Crucial for the Migration of Invasive Cancer Cells.
2017,
Pubmed
Pafumi,
Naringenin Impairs Two-Pore Channel 2 Activity And Inhibits VEGF-Induced Angiogenesis.
2017,
Pubmed
Patel,
Two-pore Channels Enter the Atomic Era: Structure of Plant TPC Revealed.
2016,
Pubmed
Patel,
Two-pore channels open up.
2018,
Pubmed
Patel,
NAADP-evoked Ca2+ signals through two-pore channel-1 require arginine residues in the first S4-S5 linker.
2017,
Pubmed
Patel,
Evolution of acidic Ca²⁺ stores and their resident Ca²⁺-permeable channels.
2015,
Pubmed
Patel,
Acidic calcium stores open for business: expanding the potential for intracellular Ca2+ signaling.
2010,
Pubmed
Patel,
Two-pore channels and disease.
2018,
Pubmed
Patel,
Function and dysfunction of two-pore channels.
2015,
Pubmed
Penny,
Isolated pores dissected from human two-pore channel 2 are functional.
2016,
Pubmed
Pihan,
e-Drug3D: 3D structure collections dedicated to drug repurposing and fragment-based drug design.
2012,
Pubmed
Pitt,
TPC2 is a novel NAADP-sensitive Ca2+ release channel, operating as a dual sensor of luminal pH and Ca2+.
2010,
Pubmed
Qin,
A direct optimization approach to hidden Markov modeling for single channel kinetics.
2000,
Pubmed
Rahman,
Two-pore channels provide insight into the evolution of voltage-gated Ca2+ and Na+ channels.
2014,
Pubmed
,
Echinobase
Ruas,
Expression of Ca²⁺-permeable two-pore channels rescues NAADP signalling in TPC-deficient cells.
2015,
Pubmed
Ruas,
TPC1 has two variant isoforms, and their removal has different effects on endo-lysosomal functions compared to loss of TPC2.
2014,
Pubmed
Ruas,
Purified TPC isoforms form NAADP receptors with distinct roles for Ca(2+) signaling and endolysosomal trafficking.
2010,
Pubmed
,
Echinobase
Sakurai,
Ebola virus. Two-pore channels control Ebola virus host cell entry and are drug targets for disease treatment.
2015,
Pubmed
She,
Structural insights into the voltage and phospholipid activation of the mammalian TPC1 channel.
2018,
Pubmed
Shoemaker,
Multiple cationic amphiphiles induce a Niemann-Pick C phenotype and inhibit Ebola virus entry and infection.
2013,
Pubmed
Simmons,
Ebolavirus Glycoprotein Directs Fusion through NPC1+ Endolysosomes.
2016,
Pubmed
Taufiq-Ur-Rahman,
Clustering of InsP3 receptors by InsP3 retunes their regulation by InsP3 and Ca2+.
2009,
Pubmed
Trott,
AutoDock Vina: improving the speed and accuracy of docking with a new scoring function, efficient optimization, and multithreading.
2010,
Pubmed
Tscherne,
An enzymatic virus-like particle assay for sensitive detection of virus entry.
2010,
Pubmed
Walseth,
Nicotinic Acid Adenine Dinucleotide 2'-Phosphate (NAADP) Binding Proteins in T-Lymphocytes.
2012,
Pubmed
Walseth,
Photoaffinity labeling of high affinity nicotinic acid adenine dinucleotide phosphate (NAADP)-binding proteins in sea urchin egg.
2012,
Pubmed
,
Echinobase
Wang,
TPC proteins are phosphoinositide- activated sodium-selective ion channels in endosomes and lysosomes.
2012,
Pubmed
Waterhouse,
SWISS-MODEL: homology modelling of protein structures and complexes.
2018,
Pubmed
Zhao,
Toremifene interacts with and destabilizes the Ebola virus glycoprotein.
2016,
Pubmed
Zong,
The two-pore channel TPCN2 mediates NAADP-dependent Ca(2+)-release from lysosomal stores.
2009,
Pubmed
